Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (799) 799
Patent (30) 30
Book Chapter (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Government Document (1) 1
Newspaper Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (276) 276
neurology (275) 275
life sciences & biomedicine (267) 267
humans (263) 263
alzheimer's disease (230) 230
neurosciences & neurology (195) 195
clinical neurology (156) 156
aged (150) 150
male (142) 142
female (139) 139
neurosciences (111) 111
aged, 80 and over (95) 95
medical sciences (88) 88
biological and medical sciences (87) 87
clinical trials (74) 74
alzheimer disease - drug therapy (73) 73
abridged index medicus (71) 71
degenerative and inherited degenerative diseases of the nervous system. leukodystrophies. prion diseases (63) 63
middle aged (63) 63
dementia (62) 62
disease progression (60) 60
alzheimer’s disease (59) 59
alzheimers disease (55) 55
alzheimer disease - diagnosis (54) 54
biomarkers (52) 52
magnetic resonance imaging (51) 51
alzheimer disease - pathology (47) 47
mild cognitive impairment (45) 45
alzheimer disease - genetics (42) 42
alzheimer disease - physiopathology (40) 40
neuropsychological tests (39) 39
brain - pathology (37) 37
cognitive ability (37) 37
drug therapy (37) 37
research (35) 35
medical colleges (34) 34
psychiatry (34) 34
amyloid beta-peptides - cerebrospinal fluid (33) 33
animals (33) 33
longitudinal studies (33) 33
neuroimaging (33) 33
alzheimer disease - cerebrospinal fluid (32) 32
pathology (32) 32
geriatrics & gerontology (31) 31
prevention (31) 31
alzheimer disease - metabolism (30) 30
medical research (30) 30
neurodegenerative diseases (30) 30
alzheimer disease - prevention & control (29) 29
amyloid beta-peptides - metabolism (29) 29
human necessities (29) 29
hygiene (29) 29
medical or veterinary science (29) 29
preparations for medical, dental, or toilet purposes (29) 29
double-blind method (28) 28
aging (27) 27
chemistry (27) 27
general & internal medicine (27) 27
medicine, general & internal (27) 27
amyloid (26) 26
apolipoprotein e4 - genetics (26) 26
cognition (26) 26
metallurgy (26) 26
brain - diagnostic imaging (25) 25
alzheimer disease (24) 24
alzheimer disease - psychology (24) 24
biochemistry (24) 24
biomarkers - cerebrospinal fluid (24) 24
medicine, experimental (24) 24
activities of daily living (23) 23
analysis (23) 23
cohort studies (23) 23
positron-emission tomography (23) 23
specific therapeutic activity of chemical compounds ormedicinal preparations (23) 23
united states (23) 23
beer (22) 22
brain (22) 22
cerebrospinal fluid (22) 22
compositions thereof (22) 22
culture media (22) 22
enzymology (22) 22
microbiology (22) 22
microorganisms or enzymes (22) 22
mutation or genetic engineering (22) 22
propagating, preserving or maintaining microorganisms (22) 22
spirits (22) 22
vinegar (22) 22
wine (22) 22
agriculture (21) 21
animal husbandry (21) 21
brain - metabolism (21) 21
care of birds, fishes, insects (21) 21
cognition & reasoning (21) 21
diagnostic imaging (21) 21
fishing (21) 21
forestry (21) 21
hunting (21) 21
new breeds of animals (21) 21
peptide fragments - cerebrospinal fluid (21) 21
psychology. psychoanalysis. psychiatry (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (825) 825
Portuguese (12) 12
French (10) 10
German (4) 4
Czech (1) 1
Hungarian (1) 1
Norwegian (1) 1
Russian (1) 1
Slovak (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
by Andrieu, Sandrine, Prof and Coley, Nicola, PhD and Lovestone, Simon, Prof and Aisen, Paul S, Prof and Vellas, Bruno, Prof
Lancet neurology, ISSN 1474-4422, 2015, Volume 14, Issue 9, pp. 926 - 944
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Learning | Clinical Trials as Topic - trends | Risk Reduction Behavior | Alzheimer Disease - prevention & control | Humans | Risk Factors | Alzheimer Disease - therapy | Antioxidants - administration & dosage | Forecasting | Prevention | Clinical trials | Alzheimer's disease | Studies | Cognition & reasoning | Alzheimers disease | Pharmaceutical industry | Dementia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Recent developments in Alzheimer's disease therapeutics
by Rafii, Michael S and Aisen, Paul S
BMC medicine, ISSN 1741-7015, 02/2009, Volume 7, Issue 1, pp. 7 - 7
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Alzheimer Disease - drug therapy | Clinical Trials as Topic | United States | Humans | Care and treatment | Amyloid beta-protein | Causes of | Diagnosis | Research | Alzheimer's disease | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
by Jack, Clifford R, Prof Dr and Knopman, David S, Prof and Jagust, William J, Prof and Petersen, Ronald C, Prof and Weiner, Michael W, Prof and Aisen, Paul S, Prof and Shaw, Leslie M, Prof and Vemuri, Prashanthi, PhD and Wiste, Heather J and Weigand, Stephen D and Lesnick, Timothy G and Pankratz, Vernon S, PhD and Donohue, Michael C, PhD and Trojanowski, John Q, Prof
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 2, pp. 207 - 216
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - physiopathology | Models, Biological | Cognition Disorders - etiology | Humans | Amyloid beta-Peptides - cerebrospinal fluid | tau Proteins - cerebrospinal fluid | Biomarkers - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Nonlinear Dynamics | Alzheimer Disease - pathology | Index Medicus | Neurodegenerative diseases | Tau protein | Brain stem | biomarkers | Cognitive ability | Evolution | beta -Amyloid | Alzheimer's disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
by Jack, Clifford R, MD and Knopman, David S, MD and Jagust, William J, MD and Shaw, Leslie M, PhD and Aisen, Paul S, MD and Weiner, Michael W, MD and Petersen, Ronald C, MD and Trojanowski, John Q, PhD
Lancet neurology, ISSN 1474-4422, 2010, Volume 9, Issue 1, pp. 119 - 128
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Brain - diagnostic imaging | Apolipoprotein E4 - genetics | Humans | tau Proteins - metabolism | Positron-Emission Tomography | Alzheimer Disease - pathology | Aging - genetics | Time Factors | Amyloid beta-Peptides - metabolism | Amyloid beta-Peptides - cerebrospinal fluid | Biomarkers - metabolism | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Plaque, Amyloid - pathology | Signal Transduction | Brain - physiopathology | Cognition Disorders - pathology | Cognition Disorders - genetics | tau Proteins - cerebrospinal fluid | Disease Progression | Aging - pathology | Plaque, Amyloid - genetics | Magnetic Resonance Imaging | Aging - physiology | Brain - pathology | Plaque, Amyloid - metabolism | Biomarkers - cerebrospinal fluid | Models, Neurological | Alzheimer Disease - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Author response: A phase 3 trial of IV immunoglobulin for Alzheimer disease
by Aisen, Paul S
Neurology, ISSN 0028-3878, 01/2018, Volume 90, Issue 3, pp. 145 - 145
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
by Doody, Rachelle S and Thomas, Ronald G and Farlow, Martin and Iwatsubo, Takeshi and Vellas, Bruno and Joffe, Steven and Kieburtz, Karl and Raman, Rema and Sun, Xiaoying and Aisen, Paul S and Siemers, Eric and Liu-Seifert, Hong and Mohs, Richard and Solanezumab Study Grp and Alzheimers Dis Cooperative Study and Solanezumab Study Group and Alzheimer's Disease Cooperative Study Steering Committee
The New England journal of medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 4, pp. 311 - 321
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Organic mental disorders. Neuropsychology | General aspects | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Alzheimer Disease - drug therapy | Male | tau Proteins - cerebrospinal fluid | Biomarkers - blood | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Amyloid beta-Peptides - blood | Activities of Daily Living | Neuropsychological Tests | Apolipoproteins E - blood | Apolipoproteins E - genetics | Treatment Failure | Intention to Treat Analysis | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Aged | Biomarkers - cerebrospinal fluid | Alzheimer Disease - blood | Solanezumab | Care and treatment | Research | Drug therapy | Alzheimer's disease | Neuroimaging | Edema | Activities of daily living | Neurodegenerative diseases | Cognitive ability | Clinical trials | Data processing | Hemorrhage | Quality of life | Studies | Neurofibrillary tangles | Gliosis | Older people | Monoclonal antibodies | Alzheimers disease | Plaques | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons
by Donohue, Michael C and Sperling, Reisa A and Petersen, Ronald and Sun, Chung-Kai and Weiner, Michael and Aisen, Paul S and Alzheimer's Dis Neuroimaging and Alzheimer’s Disease Neuroimaging Initiative
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2017, Volume 317, Issue 22, pp. 2305 - 2316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Brain - diagnostic imaging | Mental Recall | Follow-Up Studies | United States | Humans | Male | Cognition | Alzheimer Disease - cerebrospinal fluid | Brain - metabolism | Positron Emission Tomography Computed Tomography | Canada | Time Factors | Amyloid beta-Peptides - metabolism | Amyloid beta-Peptides - cerebrospinal fluid | Mental Status Schedule | Female | Aged | Alzheimer Disease - diagnostic imaging | Biomarkers - cerebrospinal fluid | Neuroimaging | Brain | Medical imaging | Statistical analysis | Neurodegenerative diseases | Memory | Cognitive ability | Positron emission | Emission | Risk | Cerebrospinal fluid | Assaying | Emissions | Boxes | Neurology | Tomography | Dementia disorders | β-Amyloid | Recall | Alzheimers disease | Alzheimer's disease | Positron emission tomography | Age
Journal Article
Details down arrow